Risk Factors for Wound Healing Complications in Sirolimus-Treated Renal Transplant Recipients

Transplantation Proceedings

Volumn 38, Issue 10, 2006, Pages 3520-3523

  Grim, S A ^a   Slover, C M ^a   Sankary, H ^a   Oberholzer, J ^a   Benedetti, E ^a   Clark, N M ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ABSCESS; ARTICLE; BLADDER DISEASE; BODY MASS; CELLULITIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; FEMALE; HIGH RISK PATIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY SURGERY; LOADING DRUG DOSE; LONG TERM CARE; LYMPHOCELE; MAINTENANCE THERAPY; MALE; OBESITY; PLASMAPHERESIS; POSTOPERATIVE COMPLICATION; PREDICTION; PRIORITY JOURNAL; RECIPIENT; RISK FACTOR; STATISTICAL SIGNIFICANCE; SURGICAL WOUND; TREATMENT DURATION; WOUND DEHISCENCE; WOUND HEALING;

ADULT; ANTILYMPHOCYTE SERUM; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MEDICAL RECORDS; MIDDLE AGED; MYCOPHENOLIC ACID; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SIROLIMUS; WOUND HEALING;

EID: 33845526773     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.10.065     Document Type: Article

References (13)

1. Sehgal S.N. Rapamune (sirolimus, rapamycin): an overview and mechanism of action. Ther Drug Monit 17 (1995) 660
2. Dean P.G., Lund W.J., Larson T.S., et al. Wound-healing complications after kidney transplantation: a prospective, randomized comparison of sirolimus and tacrolimus. Transplantation 77 (2004) 1555
3. Flechner S.M., Zhou L., Derweesh I., et al. The impact of sirolimus, mycophenolate mofetil, cyclosporine, azathioprine, and steroids on wound healing in 513 kidney-transplant recipients. Transplantation 76 (2003) 1729
4. Valente J.F., Hricik D., Weigel K., et al. Comparison of sirolimus vs mycophenolate mofetil on surgical complications and wound healing in adult kidney transplantation. Am J Transplant 3 (2003) 1128
5. Langer R.M., and Kahan B.D. Incidence, therapy, and consequences of lymphocele after sirolimus-cyclosporine-prednisone immunosuppression in renal transplant recipients. Transplantation 74 (2002) 804
6. Troppmann C., Pierce J.L., Gandhi M.M., et al. Higher surgical wound complication rates with sirolimus immunosuppression after kidney transplantation: a matched-pair pilot study. Transplantation 76 (2003) 426
7. Tondolo V., Citterio F., Massa A., et al. Lymphocele after renal transplantation: the influence of the immunosuppressive therapy. Transplant Proc 38 (2006) 1051
8. Hernandez D., Rufino M., Armas S., et al. Retrospective analysis of surgical complications following cadaveric kidney transplantation in the modern transplant era. Nephrol Dial Transplant 21 (2006) 2908
9. Rogers C.C., Hanaway M., Alloway R.R., et al. Corticosteroid avoidance ameliorates lymphocele formation and wound healing complications associated with sirolimus therapy. Transplant Proc 37 (2005) 795
10. Kuppahally S., Al-Khaldi A., Weisshaar D., et al. Wound healing complications with de novo sirolimus versus mycophenolate mofetil-based regimen in cardiac transplant recipients. Am J Transplant 6 (2006) 986
11. Anil Kumar M.S., Heifets M., Fyfe B., et al. Comparison of steroid avoidance in tacrolimus/mycophenolate mofetil and tacrolimus/sirolimus combination in kidney transplantation monitored by surveillance biopsy. Transplantation 80 (2005) 807
12. Kandaswamy R., Melancon J.K., Dunn T., et al. A prospective randomized trial of steroid-free maintenance regimens in kidney transplant recipients-an interim analysis. Am J Transplant 5 (2005) 1529
13. Friedman A.N., Miskulin D.C., Rosenberg I.H., et al. Demographics and trends in overweight and obesity in patients at time of kidney transplantation. Am J Kidney Dis 41 (2003) 480